MYC and central nervous system cancer: This is consistent with reports demonstrating that SUMOylation-dependent transcriptional sub-programming is required for Myc-driven tumorigenesis, and more so implicating SAE1 in the progression of human glioma and gastric cancer through the activation of SUMOylation-mediated oncogenic signaling pathways [11,12,13].